{"id":"https://openalex.org/W2084711752","doi":"https://doi.org/10.1111/j.1365-2036.2009.04012.x","title":"Apolipoprotein B\u2010associated cholesterol is a determinant of treatment outcome in patients with chronic hepatitis C virus infection receiving anti\u2010viral agents interferon\u2010alpha and ribavirin","display_name":"Apolipoprotein B\u2010associated cholesterol is a determinant of treatment outcome in patients with chronic hepatitis C virus infection receiving anti\u2010viral agents interferon\u2010alpha and ribavirin","alternate_titles":[],"publication_year":2009,"publication_date":"2009-05-21","ids":{"openalex":"https://openalex.org/W2084711752","doi":"https://doi.org/10.1111/j.1365-2036.2009.04012.x","mag":"2084711752","pmid":"https://pubmed.ncbi.nlm.nih.gov/19392865"},"language":"en","primary_location":{"id":"doi:10.1111/j.1365-2036.2009.04012.x","doi":"https://doi.org/10.1111/j.1365-2036.2009.04012.x","is_oa":true,"landing_page_url":"https://doi.org/10.1111/j.1365-2036.2009.04012.x","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1365-2036.2009.04012.x","source":{"id":"https://openalex.org/S158079644","display_name":"Alimentary Pharmacology & Therapeutics","issn_l":"0269-2813","issn":["0269-2813","1365-2036"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Alimentary Pharmacology &amp; Therapeutics","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2084711752"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","datacite","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1365-2036.2009.04012.x","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5084947428","display_name":"David A. Sheridan","orcid":"https://orcid.org/0000-0001-5100-814X","observed_orcids":["https://orcid.org/0000-0001-5100-814X"]},"institutions":[{"id":"https://openalex.org/I84884186","display_name":"Newcastle University","ror":"https://ror.org/01kj2bm70","country_code":"GB","type":"education","lineage":["https://openalex.org/I84884186"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"D. A. SHERIDAN","raw_affiliation_strings":["Liver Research Group, Institute of Cellular Medicine, Newcastle University, Newcastleupon Tyne, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Liver Research Group, Institute of Cellular Medicine, Newcastle University, Newcastleupon Tyne, UK","institution_ids":["https://openalex.org/I84884186"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045374413","display_name":"David Price","orcid":"https://orcid.org/0000-0002-0562-7326","observed_orcids":["https://orcid.org/0000-0002-0562-7326","https://orcid.org/0000-0003-1897-3321"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"D. A. PRICE","raw_affiliation_strings":["Department of Infectious Diseases, Newcastle General Hospital"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Infectious Diseases, Newcastle General Hospital","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5086311843","display_name":"Matthias L. Schmid","orcid":"https://orcid.org/0000-0003-1058-8832","observed_orcids":["https://orcid.org/0000-0003-1058-8832"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"M. L. SCHMID","raw_affiliation_strings":["Department of Infectious Diseases, Newcastle General Hospital"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Infectious Diseases, Newcastle General Hospital","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111664133","display_name":"G. L. Toms","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I84884186","display_name":"Newcastle University","ror":"https://ror.org/01kj2bm70","country_code":"GB","type":"education","lineage":["https://openalex.org/I84884186"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"G. L. TOMS","raw_affiliation_strings":["Liver Research Group, Institute of Cellular Medicine, Newcastle University"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Liver Research Group, Institute of Cellular Medicine, Newcastle University","institution_ids":["https://openalex.org/I84884186"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112770180","display_name":"Peter T. Donaldson","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I84884186","display_name":"Newcastle University","ror":"https://ror.org/01kj2bm70","country_code":"GB","type":"education","lineage":["https://openalex.org/I84884186"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"P. DONALDSON","raw_affiliation_strings":["Liver Research Group, Institute of Cellular Medicine, Newcastle University"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Liver Research Group, Institute of Cellular Medicine, Newcastle University","institution_ids":["https://openalex.org/I84884186"]}]},{"author_position":"middle","author":{"id":null,"display_name":"D. NEELY","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2800516725","display_name":"Royal Victoria Infirmary","ror":"https://ror.org/01p19k166","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I2800516725","https://openalex.org/I2801663869"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"D. NEELY","raw_affiliation_strings":["Department of Clinical Biochemistry, Royal Victoria Infirmary, Newcastle upon Tyne, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Clinical Biochemistry, Royal Victoria Infirmary, Newcastle upon Tyne, UK","institution_ids":["https://openalex.org/I2800516725"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5105273804","display_name":"Margaret F. Bassendine","orcid":"https://orcid.org/0000-0002-0958-9232","observed_orcids":["https://orcid.org/0000-0002-0958-9232"]},"institutions":[{"id":"https://openalex.org/I84884186","display_name":"Newcastle University","ror":"https://ror.org/01kj2bm70","country_code":"GB","type":"education","lineage":["https://openalex.org/I84884186"]}],"countries":["GB"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"M. F. BASSENDINE","raw_affiliation_strings":["Liver Research Group, Institute of Cellular Medicine, Newcastle University"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Liver Research Group, Institute of Cellular Medicine, Newcastle University","institution_ids":["https://openalex.org/I84884186"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5105273804"],"corresponding_institution_ids":["https://openalex.org/I84884186"],"apc_list":{"value":5250,"currency":"USD","value_usd":5250},"apc_paid":null,"fwci":3.3003,"has_fulltext":true,"cited_by_count":47,"citation_normalized_percentile":{"value":0.92212755,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":87,"max":98},"biblio":{"volume":"29","issue":"12","first_page":"1282","last_page":"1290"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10151","display_name":"Hepatitis C virus research","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2721","display_name":"Hepatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10151","display_name":"Hepatitis C virus research","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2721","display_name":"Hepatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10394","display_name":"Lipoproteins and Cardiovascular Health","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10351","display_name":"Liver Disease Diagnosis and Treatment","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2721","display_name":"Hepatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/chronic-hepatitis-c","display_name":"chronic hepatitis C","score":0.9319999814033508},{"id":"https://openalex.org/keywords/non-hdl-cholesterol","display_name":"non-HDL cholesterol","score":0.9909999966621399},{"id":"https://openalex.org/keywords/interferon-alpha","display_name":"interferon-alpha","score":0.9359999895095825},{"id":"https://openalex.org/keywords/ribavirin","display_name":"ribavirin","score":0.9990000128746033},{"id":"https://openalex.org/keywords/sustained-virologic-response","display_name":"sustained virological response","score":0.9869999885559082},{"id":"https://openalex.org/keywords/hcv-genotype-3","display_name":"HCV genotype 3","score":0.7360000014305115},{"id":"https://openalex.org/keywords/hcv-genotype-1","display_name":"HCV genotype 1","score":0.8920000195503235},{"id":"https://openalex.org/keywords/very-low-density-lipoprotein","display_name":"VLDL","score":0.8009999990463257},{"id":"https://openalex.org/keywords/apolipoprotein-b-100","display_name":"apolipoprotein B-100","score":0.8069999814033508},{"id":"https://openalex.org/keywords/lipid-profile","display_name":"lipid profile","score":0.42800000309944153},{"id":"https://openalex.org/keywords/treatment-outcome-predictors","display_name":"treatment outcome predictors","score":0.6399999856948853},{"id":"https://openalex.org/keywords/lipoprotein-receptors","display_name":"lipoprotein receptors","score":0.8019999861717224}],"concepts":[{"id":"https://openalex.org/C62746215","wikidata":"https://www.wikidata.org/wiki/Q14890615","display_name":"Apolipoprotein B","level":3,"score":0.7157772183418274},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6813579201698303},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6674434542655945},{"id":"https://openalex.org/C2780040827","wikidata":"https://www.wikidata.org/wiki/Q421862","display_name":"Ribavirin","level":4,"score":0.6294278502464294},{"id":"https://openalex.org/C2776408679","wikidata":"https://www.wikidata.org/wiki/Q708693","display_name":"Hepatitis C virus","level":3,"score":0.6191198229789734},{"id":"https://openalex.org/C156957248","wikidata":"https://www.wikidata.org/wiki/Q1862216","display_name":"Odds ratio","level":2,"score":0.5540049076080322},{"id":"https://openalex.org/C2780072125","wikidata":"https://www.wikidata.org/wiki/Q28350","display_name":"Lipoprotein","level":3,"score":0.5500333905220032},{"id":"https://openalex.org/C2776455275","wikidata":"https://www.wikidata.org/wiki/Q154869","display_name":"Hepatitis C","level":2,"score":0.5313022136688232},{"id":"https://openalex.org/C2778163477","wikidata":"https://www.wikidata.org/wiki/Q43656","display_name":"Cholesterol","level":2,"score":0.5189099907875061},{"id":"https://openalex.org/C8243546","wikidata":"https://www.wikidata.org/wiki/Q419074","display_name":"Very low-density lipoprotein","level":4,"score":0.498584508895874},{"id":"https://openalex.org/C2909179924","wikidata":"https://www.wikidata.org/wiki/Q6046488","display_name":"Alpha interferon","level":3,"score":0.46001434326171875},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.4494287371635437},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.4091709852218628},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.37508440017700195},{"id":"https://openalex.org/C159047783","wikidata":"https://www.wikidata.org/wiki/Q7215","display_name":"Virology","level":1,"score":0.34808942675590515},{"id":"https://openalex.org/C2776178377","wikidata":"https://www.wikidata.org/wiki/Q188269","display_name":"Interferon","level":2,"score":0.3214799761772156},{"id":"https://openalex.org/C2522874641","wikidata":"https://www.wikidata.org/wiki/Q808","display_name":"Virus","level":2,"score":0.2960191071033478}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000998","descriptor_name":"Antiviral Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D001055","descriptor_name":"Apolipoproteins B","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D001055","descriptor_name":"Apolipoproteins B","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D002784","descriptor_name":"Cholesterol","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D002784","descriptor_name":"Cholesterol","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011237","descriptor_name":"Predictive Value of Tests","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012189","descriptor_name":"Retrospective Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012254","descriptor_name":"Ribavirin","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D015999","descriptor_name":"Multivariate Analysis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016898","descriptor_name":"Interferon-alpha","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D019698","descriptor_name":"Hepatitis C, Chronic","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true}],"locations_count":4,"locations":[{"id":"doi:10.1111/j.1365-2036.2009.04012.x","doi":"https://doi.org/10.1111/j.1365-2036.2009.04012.x","is_oa":true,"landing_page_url":"https://doi.org/10.1111/j.1365-2036.2009.04012.x","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1365-2036.2009.04012.x","source":{"id":"https://openalex.org/S158079644","display_name":"Alimentary Pharmacology & Therapeutics","issn_l":"0269-2813","issn":["0269-2813","1365-2036"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Alimentary Pharmacology &amp; Therapeutics","raw_type":"journal-article"},{"id":"pmid:19392865","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/19392865","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Alimentary pharmacology & therapeutics","raw_type":"Journal Article"},{"id":"doi:10.25405/ncl.34102017","doi":"https://doi.org/10.25405/ncl.34102017","is_oa":true,"landing_page_url":"https://doi.org/10.25405/ncl.34102017","pdf_url":null,"source":{"id":"https://openalex.org/S4306402485","display_name":"Newcastle University ePrints (Newcastle Univesity)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I84884186","host_organization_name":"Newcastle University","host_organization_lineage":["https://openalex.org/I84884186"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"JournalArticle"},{"id":"doi:10.25405/ncl.34102017.v1","doi":"https://doi.org/10.25405/ncl.34102017.v1","is_oa":true,"landing_page_url":"https://doi.org/10.25405/ncl.34102017.v1","pdf_url":null,"source":{"id":"https://openalex.org/S4306402485","display_name":"Newcastle University ePrints (Newcastle Univesity)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I84884186","host_organization_name":"Newcastle University","host_organization_lineage":["https://openalex.org/I84884186"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"JournalArticle"}],"best_oa_location":{"id":"doi:10.1111/j.1365-2036.2009.04012.x","doi":"https://doi.org/10.1111/j.1365-2036.2009.04012.x","is_oa":true,"landing_page_url":"https://doi.org/10.1111/j.1365-2036.2009.04012.x","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1365-2036.2009.04012.x","source":{"id":"https://openalex.org/S158079644","display_name":"Alimentary Pharmacology & Therapeutics","issn_l":"0269-2813","issn":["0269-2813","1365-2036"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Alimentary Pharmacology &amp; Therapeutics","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[],"funders":[{"id":"https://openalex.org/F4320307115","display_name":"Bristol-Myers Squibb","ror":"https://ror.org/00gtmwv55"},{"id":"https://openalex.org/F4320308573","display_name":"Gilead Sciences","ror":"https://ror.org/056546b03"},{"id":"https://openalex.org/F4320311904","display_name":"Wellcome Trust","ror":"https://ror.org/029chgv08"},{"id":"https://openalex.org/F4320334626","display_name":"Medical Research Council","ror":"https://ror.org/03x94j517"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2084711752.pdf","grobid_xml":"https://content.openalex.org/works/W2084711752.grobid-xml"},"referenced_works_count":52,"referenced_works":["https://openalex.org/W1964566637","https://openalex.org/W1968000667","https://openalex.org/W1970828145","https://openalex.org/W1977472360","https://openalex.org/W1978436940","https://openalex.org/W1979907603","https://openalex.org/W1986505810","https://openalex.org/W1993956314","https://openalex.org/W2000991693","https://openalex.org/W2001070009","https://openalex.org/W2002995518","https://openalex.org/W2003143622","https://openalex.org/W2003300591","https://openalex.org/W2003759407","https://openalex.org/W2007572616","https://openalex.org/W2008402685","https://openalex.org/W2015334014","https://openalex.org/W2022557944","https://openalex.org/W2036288083","https://openalex.org/W2036306822","https://openalex.org/W2041186969","https://openalex.org/W2041220983","https://openalex.org/W2052480299","https://openalex.org/W2054862747","https://openalex.org/W2059599270","https://openalex.org/W2062802394","https://openalex.org/W2066644955","https://openalex.org/W2073293272","https://openalex.org/W2091217953","https://openalex.org/W2094733152","https://openalex.org/W2094922632","https://openalex.org/W2104753383","https://openalex.org/W2106611664","https://openalex.org/W2106791445","https://openalex.org/W2109457390","https://openalex.org/W2113552969","https://openalex.org/W2120165528","https://openalex.org/W2121101037","https://openalex.org/W2122433263","https://openalex.org/W2127274349","https://openalex.org/W2127685726","https://openalex.org/W2136004157","https://openalex.org/W2139342290","https://openalex.org/W2139731250","https://openalex.org/W2152112546","https://openalex.org/W2153747938","https://openalex.org/W2155368883","https://openalex.org/W2156067255","https://openalex.org/W2157544578","https://openalex.org/W2159913400","https://openalex.org/W2172002207","https://openalex.org/W4238719302"],"related_works":["https://openalex.org/W2113552969","https://openalex.org/W2175235962","https://openalex.org/W2104753383","https://openalex.org/W4391979134","https://openalex.org/W2883915437","https://openalex.org/W2088767361","https://openalex.org/W2981283760","https://openalex.org/W1989035554","https://openalex.org/W2033665928","https://openalex.org/W2038620066"],"abstract_inverted_index":{"BACKGROUND:":[0],"Hepatitis":[1],"C":[2,59],"virus":[3],"(HCV)":[4],"co-opts":[5],"very-low-density":[6],"lipoprotein":[7,87,198],"(VLDL)":[8],"pathways":[9],"for":[10,193],"replication,":[11],"secretion":[12],"and":[13,17,29,35,38,68,78,85,116,187],"entry":[14,195],"into":[15],"hepatocytes":[16],"associates":[18],"with":[19,102,171],"apolipoprotein":[20],"B":[21],"(apoB)":[22],"in":[23,134,174],"plasma.":[24],"Each":[25],"VLDL":[26],"contains":[27],"apoB-100":[28],"variable":[30],"amounts":[31],"of":[32,55,119,150],"apolipoproteins":[33],"E":[34],"C,":[36],"cholesterol":[37,89,114,167],"triglycerides.":[39],"AIM:":[40],"To":[41],"determine":[42],"whether":[43],"baseline":[44],"lipid":[45,81],"levels":[46],"predicted":[47],"treatment":[48,103,172],"outcome.":[49,104],"METHODS:":[50],"Retrospective":[51],"analysis":[52,97],"was":[53,92,107,131,146],"performed":[54],"250":[56],"chronic":[57],"hepatitis":[58],"(CHC)":[60],"patients":[61,176],"who":[62],"had":[63,71],"received":[64],"anti-viral":[65,178],"agents":[66],"interferon-alpha":[67],"ribavirin;":[69],"165":[70],"a":[72],"sustained":[73],"virological":[74],"response":[75],"(SVR).":[76],"Pre-":[77],"post-treatment":[79],"nonfasting":[80],"profiles":[82],"were":[83],"measured":[84],"non-high-density":[86],"(non-HDL)":[88],"(i.e.":[90],"apoB-associated)":[91],"calculated.":[93],"Binary":[94],"logistic":[95],"regression":[96],"assessed":[98],"factors":[99],"independently":[100],"associated":[101,170],"RESULTS:":[105],"There":[106],"an":[108],"independent":[109],"association":[110],"between":[111,184],"higher":[112],"apoB-associated":[113,166],"(non-HDL-C)":[115],"increased":[117],"odds":[118],"SVR":[120,157],"(odds":[121],"ratio":[122],"2.09,":[123],"P":[124,161],"=":[125,143,154,158],"0.042).":[126],"In":[127],"multivariate":[128],"analysis,":[129],"non-HDL-C":[130,153],"significantly":[132],"lower":[133],"HCV":[135,190],"genotype":[136,140],"3":[137],"(g3)":[138],"than":[139],"1":[141],"(P":[142],"0.007);":[144],"this":[145],"reversible":[147],"upon":[148],"eradication":[149],"HCVg3":[151],"(pre-treatment":[152],"2.8":[155],"mmol/L,":[156,160],"3.6":[159],"<":[162],"0.001).":[163],"CONCLUSIONS:":[164],"Higher":[165],"is":[168],"positively":[169],"outcome":[173],"CHC":[175],"receiving":[177],"therapy,":[179],"possibly":[180],"due":[181],"to":[182],"competition":[183],"apoB-containing":[185],"lipoproteins":[186],"infectious":[188],"low-density":[189],"lipo-viral":[191],"particles":[192],"hepatocyte":[194],"via":[196],"shared":[197],"receptors.":[199]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2084711752","counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":2},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":1},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":5},{"year":2016,"cited_by_count":3},{"year":2015,"cited_by_count":4},{"year":2014,"cited_by_count":4},{"year":2013,"cited_by_count":6},{"year":2012,"cited_by_count":6}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2016-06-24T00:00:00"}
